1

infection
2014

K Tabynov, A Sansyzbay, Z Kydyrbayev, B Yespembetov, S Ryskeldinova, ...

Virology journal 11, 1-13, 2014

55

2

Novel influenza virus vectors expressing Brucella L7/L12 or Omp16 proteins in cattle induced a strong T-cell immune response, as well as high protectiveness against B. abortus?…
2014

K Tabynov, Z Kydyrbayev, S Ryskeldinova, B Yespembetov, N Zinina, ...

Vaccine 32 (18), 2034-2041, 2014

49

3

Novel vector vaccine against Brucella abortus based on influenza A viruses expressing Brucella L7/L12 or Omp16 proteins: evaluation of protection in pregnant heifers
2014

K Tabynov, B Yespembetov, A Sansyzbay

Vaccine 32 (45), 5889-5892, 2014

30

4

Significance of high-containment biological laboratories performing work during the COVID-19 pandemic: Biosafety level-3 and-4 labs
2021

KB Yeh, K Tabynov, FK Parekh, I Mombo, K Parker, K Tabynov, ...

Frontiers in bioengineering and biotechnology 9, 720315, 2021

24

5

infection in?…
2017

A Mailybayeva, B Yespembetov, S Ryskeldinova, N Zinina, A Sansyzbay, ...

PLoS One 12 (10), e0186484, 2017

23

6

First evaluation of an influenza viral vector based Brucella abortus vaccine in sheep and goats: Assessment of safety, immunogenicity and protective efficacy against Brucella?…
2016

K Tabynov, B Yespembetov, N Matikhan, S Ryskeldinova, N Zinina, ...

Veterinary microbiology 197, 15-20, 2016

22

7

An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection against Covid-19 infection and transmission
2022

K Tabynov, N Turebekov, M Babayeva, G Fomin, T Yerubayev, ...

npj Vaccines 7 (1), 24, 2022

21

8

An influenza viral vector Brucella abortus vaccine induces good cross-protection against Brucella melitensis infection in pregnant heifers
2015

K Tabynov, S Ryskeldinova, A Sansyzbay

Vaccine 33 (31), 3619-3623, 2015

21

9

Safety and immunogenicity of a novel cold‐adapted modified‐live equine influenza virus vaccine
2014

K Tabynov, Z Kydyrbayev, S Ryskeldinova, N Assanzhanova, ...

Australian veterinary journal 92 (11), 450-457, 2014

19

10

vaccine: a novel vaccine candidate for veterinary practice
2016

K Tabynov

Expert Review of Vaccines 15 (10), 1237-1239, 2016

18

11

Inactivated porcine reproductive and respiratory syndrome virus vaccine adjuvanted with Montanide™ Gel 01 ST elicits virus-specific cross-protective inter-genotypic response?…
2016

K Tabynov, A Sansyzbay, Z Tulemissova, K Tabynov, S Dhakal, ...

Veterinary microbiology 192, 81-89, 2016

18

12

Safety of the novel vector vaccine against Brucella abortus based on recombinant influenza viruses expressing Brucella L7/L12 and OMP16 proteins, in cattle
2015

K Tabynov, Z Kydyrbayev, S Ryskeldinova, B Yespembetov, N Syrymkyzy, ...

J. Vaccines Immun.–2014.–1 101, 2015

18

13

Immunogenic and protective properties of the first Kazakhstan vaccine against pandemic influenza A (H1N1) pdm09 in ferrets
2012

K Tabynov, Z Kydyrbayev, A Sansyzbay, B Khairullin, S Ryskeldinova, ...

Virologica sinica 27, 344-351, 2012

17

14

A spike protein-based subunit SARS-CoV-2 vaccine for pets: safety, immunogenicity, and protective efficacy in juvenile cats
2022

K Tabynov, M Orynbassar, L Yelchibayeva, N Turebekov, T Yerubayev, ...

Frontiers in Veterinary Science 9, 815978, 2022

16

15

Prime-booster vaccination of cattle with an influenza viral vector Brucella abortus vaccine induces a long-term protective immune response against Brucella abortus infection
2016

K Tabynov, B Yespembetov, S Ryskeldinova, N Zinina, Z Kydyrbayev, ...

Vaccine 34 (4), 438-444, 2016

15

16

A new candidate vaccine for human brucellosis based on influenza viral vectors: a preliminary investigation for the development of an immunization schedule in a guinea pig model
2021

D Bugybayeva, Z Kydyrbayev, N Zinina, N Assanzhanova, ...

Infectious Diseases of Poverty 10 (01), 56-65, 2021

13

17

Genetic diversity of avian avulavirus 1 (Newcastle disease virus genotypes VIg and VIIb) circulating in wild birds in Kazakhstan
2018

MB Orynbayev, S Fereidouni, AR Sansyzbai, BA Seidakhmetova, ...

Archives of virology 163 (7), 1949-1954, 2018

13

18

Duration of the protective immune response after prime and booster vaccination of yearlings with a live modified cold-adapted viral vaccine against equine influenza
2014

K Tabynov, Z Kydyrbayev, S Ryskeldinova, N Assanzhanova, ...

Vaccine 32 (25), 2965-2971, 2014

12

19

Comparison of different methods of purification and concentration in production of influenza vaccine
2017

NN Asanzhanova, SZ Ryskeldinova, OV Chervyakova, BM Khairullin, ...

Bulletin of Experimental Biology and Medicine 164, 229-232, 2017

11

20

vaccine in pregnant heifers
2015

K Tabynov, S Ryskeldinova, Z Kydyrbayev, A Sansyzbay

Ci?ncia Rural 46, 114-118, 2015

11

21

Analysis of the efficacy of an adjuvant-based inactivated pandemic H5N1 influenza virus vaccine
2019

A Nurpeisova, M Kassenov, N Rametov, K Tabynov, GJ Renukaradhya, ...

Archives of virology 164, 1027-1036, 2019

10

22

Avian influenza virus H5N1 subtype A diagnosed in sick and dead wild and domestic birds in Pavlodar oblast, Republic of Kazakhstan
2007

SM Mamadaliyev, ZK Koshemetov, VM Matveyeva, ZK Kydyrbayev, ...

Afr J Agric Res 2 (8), 360-365, 2007

10

23

Nanobody Nb6 fused with porcine IgG Fc as the delivering tag to inhibit porcine reproductive and respiratory syndrome virus replication in porcine alveolar macrophages
2021

L Zhang, L Wang, S Cao, H Lv, J Huang, G Zhang, K Tabynov, Q Zhao, ...

Veterinary Research 52, 1-14, 2021

9

24

Simultaneous subcutaneous and conjunctival administration of the influenza viral vector based Brucella abortus vaccine to pregnant heifers provides better protection against B?…
2016

K Tabynov, M Orynbayev, GJ Renukaradhya, A Sansyzbay

Vaccine 34 (42), 5049-5052, 2016

9

25

Development of human vectored brucellosis vaccine formulation: assessment of safety and protectiveness of influenza viral vectors expressing Brucella immunodominant proteins in?…
2020

D Bugybayeva, S Ryskeldinova, N Zinina, M Sarmykova, ...

BioMed Research International 2020, 2020

8

26

Beta-propiolactone inactivated bivalent bluetongue virus vaccine containing Montanide ISA-71VG adjuvant induces long-term immune response in sheep against serotypes 4 and 16?…
2018

K Zhugunissov, Y Bulatov, D Taranov, Z Yershebulov, Z Koshemetov, ...

Veterinary microbiology 226, 23-30, 2018

8

27

A recombinant Artemisia vulgaris pollen adjuvanted Art v 1 protein-based vaccine treats allergic rhinitis and bronchial asthma using pre-and co-seasonal ultrashort?…
2022

M Babayeva, K Tabynov, T Nurpeisov, G Fomin, GJ Renukaradhya, ...

Frontiers in Immunology 13, 983621, 2022

6

28

Evaluation of a novel adjuvanted vaccine for ultrashort regimen therapy of artemisia pollen-induced allergic bronchial asthma in a mouse model
2022

K Tabynov, M Babayeva, T Nurpeisov, G Fomin, T Nurpeisov, ...

Frontiers in immunology 13, 828690, 2022

6

29

Pulmonary inflammatory response to influenza virus infection in pigs is regulated by DAP12 and macrophage M1 and M2 phenotypes
2020

J Hiremath, S Renu, K Tabynov, GJ Renukaradhya

Cellular Immunology 352, 104078, 2020

6

30

Operationalizing cooperative research for infectious disease surveillance: lessons learned and ways forward
2021

KB Yeh, FK Parekh, K Tabynov, K Tabynov, R Hewson, JM Fair, ...

Frontiers in Public Health 9, 659695, 2021

5

31

Immunogenicity of the inactivated oil emulsion influenza A (H5N1) vaccine in chickens
2010

ZK Kydyrbayev, KK Tabynov, SZ Ryskeldynova, SM Mamadaliyev, ...

Agriculture and Biologi Journal of North America.–2010,–Р, 201-207, 2010

5

32

Vaccine for Cattle in Kazakhstan: Age-Wise Safety and Efficacy Studies
2021

S Ryskeldinova, N Zinina, Z Kydyrbayev, B Yespembetov, Y Kozhamkulov, ...

Frontiers in cellular and infection microbiology 11, 669196, 2021

4

33

A new safe and effective cold-adapted modified live equine influenza virus vaccine that enables the differentiation of infected from vaccinated animals
2016

T Kaissar

Microbiology Independent Research Journal 3 (1), 68-73, 2016

4

34

An intranasal vaccine comprising SARS-CoV-2 spike receptor-binding domain protein entrapped in mannose-conjugated chitosan nanoparticle provides protection in hamsters
2023

K Tabynov, M Solomadin, N Turebekov, M Babayeva, G Fomin, ...

Scientific Reports 13 (1), 12115, 2023

3

35

Evaluation of duration of immunogenicity and protective efficacy of improved influenza viral vector–based Brucella abortus vaccine against Brucella melitensis infection in?…
2020

A Mailybayeva, S Ryskeldinova, N Zinina, EM Zhou, GJ Renukaradhya, ...

Frontiers in Veterinary Science 7, 58, 2020

3

36

Genetic stability of the HA, NA, and NS genes of the recombinant vector virus Flu-NS1-124-Omp16 (H5N1) expressing the brucellar gene
2015

SO Sadikaliyeva, KT Sultankulova, KA Shorayeva, VM Strochkov, ...

Voprosy Virusologii 60 (4), 18-23, 2015

2

37

Preliminary assessment of safety and immunogenicity of an inactivated whole-virion vaccine against influenza A (H1N1) Pdm09 containing aluminum hydroxide adjuvant: a randomized?…
2013

K Tabynov, B Khairullin, Z Kydyrbayev, N Sandybayev, M Stukova, ...

2

38

Evaluation of a SARS-CoV-2 spike protein ectodomain subunit vaccine with a squalene emulsion adjuvant in rodents and rhesus macaques
2023

M Solomadin, K Tabynov, N Petrovsky, K Tabynov

Human Vaccines & Immunotherapeutics 19 (2), 2258571, 2023

1

39

SARS-CoV-2 Spike receptor-binding domain entrapped in mannose-conjugated chitosan nanoparticle vaccine delivered intranasal elicits local and systemic Th1 and Th2 immune?…
2022

K Tabynov, M Solomadin, N Turebekov, M Babayeva, G Fomin, ...

1

40

Engineered adjuvants and carriers for an animal infectious disease vaccine
2021

S Renu, HL Wilson, K Tabynov, J Hiremath

Frontiers in Bioengineering and Biotechnology 9, 692634, 2021

1

41

COMMISSION TRIALS OF THE MANUFACTURING TECHNOLOGY, AND PHYSICAL AND IMMUNOBIOLOGICAL PROPERTIES, OF A NOVEL LIVE MODIFIED COLD-ADAPTED VIRAL VACCINE AGAINST EQUINE INFLUENZA
2016

KK Tabynov, NN Assanzhanova, SZ Ryskeldinova, YM Kozhamkulov, ...

Eurasian Journal of Applied Biotechnology, 2016

1

42

Optimization of influenza A and B viruses cultivation conditions for preparation of trivalent seasonal influenza split vaccine.
2015

I Akzhunusova, N Assanzhanova, K Tabynov, B Abdrakhmanova, ...

1

43

OPEN ACCESS EDITED BY
2024

M Sanyal, K Tabynov, B Schepens, IB Esmagambetov, EI Ryabovat, ...

Methods in Vaccines and Molecular Therapeutics: 2022, 138, 2024

0

44

Molecular Model of Inhibition of the Catalytic Fragment of Domain ExoN of Exoribonuclease of Virus SARS-CoV-2-betacoronavirus B by Drug FS-1 Containing Molecular Iodine and?…
2024

G Yuldasheva, IS Korotetskiy, K Tabynov, K Tabynov, AI Ilin

0

45

Author Correction: An intranasal vaccine comprising SARS‑CoV‑2 spike receptor‑binding domain protein entrapped in mannose‑conjugated chitosan nanoparticle provides protection?…
2023

K Tabynov, M Solomadin, N Turebekov, M Babayeva, G Fomin, ...

Scientific Reports 13, 2023

0

46

O5-1 Registered Influenza Viral Vector Based Brucella abortus Vaccine for Cattle in Kazakhstan: Age-Wise Safety and Efficacy Studies
2022

S Ryskeldinova, N Zinina, Z Kydyrbayev, B Yespembetov, Y Kozhamkulov, ...

Brucellosis 2022 International Research Conference, 2022

0

47

A Spike protein-based subunit SARS-CoV-2 vaccine for pets: safety, immunogenicity, and protective efficacy in juvenile cats (preprint)
2021

K Tabynov, M Orynbassar, L Yelchibayeva, N Turebekov, T Yerubayev, ...

0

48

A new candidate vaccine for human brucellosis based on influenza viral vectors: development of immunization schedule in guinea pig model
2020

D Bugybayeva, Z Kydyrbayev, N Zinina, N Assanzhanova, ...

0

49

Corrigendum to'Beta-propiolactone inactivated bivalent bluetongue virus vaccine containing montanide ISA-71VG adjuvant induces long-term immune response in sheep against?…
2019

K Zhugunissov, Y Bulatov, D Taranov, Z Yershebulov, Z Koshemetov, ...

Veterinary microbiology 230, 291, 2019

0

50

TOWARDS NEW HUMAN BRUCELLOSIS VACCINE: SELECTING IMMUNIZATION MODALITY
2019

DA Bugybayeva, SZ Ryskeldinova, ZK Kydyrbayev, YM Kozhamkulov, ...

Медицина (Алматы), 35-40, 2019

0

51

TECHNOLOGICAL ASPECTS OF MANUFACTURING THE FIRST KAZAKHSTAN SEASONAL INFLUENZA SPLIT VACCINE
2016

NN Assanzhanova, ZK Kydyrbayev, SZ Ryskeldinova, MM Kassenov, ...

Eurasian Journal of Applied Biotechnology, 2016

0

52

Grupo de pesquisa desenvolve vacina para brucelose bovina segura para uso em novilhas prenhes
2016

K Tabynov

0

53

Seguran?a de uma nova vacina vetorial empregando o v?rus influenza para Brucella abortus em novilhas prenhes
2015

K Tabynov, S Ryskeldinova, Z Kydyrbayev, A Sansyzbay

Ci?ncia Rural 46, 114-118, 2015

0

54

Safety and immunogenicity of a novel cold-adapted modified-live equine influenza virus vaccine (vol 92, pg 450, 2014)
2015

A Jackson, K Tabynov, Z Kydyrbayev, S Ryskeldinova, N Assanzhanova, ...

AUSTRALIAN VETERINARY JOURNAL 93 (3), 52-52, 2015

0

55

Evaluate the immunogenicity antibrucellar vaccine vector model of guinea pigs
2014

BA Yespembetov, NS Syrym, Z NN, KK Tabynov, RK Nissanova, ...

Life Science Journal 11 (6 SPEC. ISSUE), 565-568, 2014

0

56

Сравнительный генетический анализ NS гена рекомбинантных гриппозных векторов Flu-NS1-80-L7/L12 (H5N1) и Flu-NS1-124-L7/L12 (H5N1), экспрессирующих бруцеллезный антиген
2014

GO Shynybekova, KK Akylbayeva, SO Sadikaliyeva, KT Sultankulova, ...

Experimental Biology 61 (2), 128-134, 2014

0

57

Preliminary Assessment of Safety and Immunogenicity of an Inactivated Whole-Virion Vaccine against Influenza А (H1N1) Pdm09 Containing Aluminum Hydroxide Adjuvant: A Randomized?…
2013

K Tabynov, B Khairullin, Z Kydyrbayev, N Sandybayev, M Stukova

J Vaccines Vaccin 4 (205), 2, 2013

0

58

Technological approaches to development of whole-virion inactivated vaccine from recombinant strain against A/H5N1 influenza in the Republic of Kazakhstan
2012

K ZhK, SM Mamadaliev, NN Asanzhanova, KK Tabynov, OV Cherviakova, ...

Zhurnal Mikrobiologii, Epidemiologii i Immunobiologii, 54-59, 2012

0

59

Significance of High-Containment Biological Laboratories Performing Work During the COVID-19 Pandemic: BSL-3 and-4 Labs

KB Yeh, K Tabynov, FK Parekh, I Mombo, K Parker, K Tabynov, ...

0

60

1Южно-Казахстанский государственный университет им. М. Ауезова, г. Шымкент 2Юго-Западный научно-исследовательский институт растениеводства и животноводства, г. Шымкент?…

IK Akzhunusova, KK Tabynov, NN Assanzhanova, SZ Ryskeldynova, ...

0

61

A Subunit Sars-Cov-2 Spike Protein Oil Adjuvanted Vaccine Provides Complete Protection Against Infection and Viral Transmission

K Tabynov, M Solomadin, N Turebekov, M Babayeva, G Fomin, ...

16TH VACCINE CONGRESS P 1, 0

0